WHWK
Whitehawk Therapeutics, Inc.
3.40$
-5.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.2% | – | – | – | – | – | – | +130.7% | +49.0% | +23.5% | +23.1% | +12.2% | +5.7% | -3.9% | +6.2% | -15.4% | +15.4% | +16.7% | +0.4% | -1.3% | -100.0% | – | – | – | – | – | |
| – | +76.0% | – | – | – | – | – | – | – | +90.5% | +73.9% | -62.6% | +138.3% | +2,541.0% | -9.9% | +8.8% | +4.0% | -2.6% | -22.1% | +40.1% | -95.0% | -97.9% | -68.8% | -80.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | +112.8% | +45.5% | +18.0% | +37.0% | +6.7% | -245.5% | – | – | – | – | – | – | – | -100.3% | – | – | – | – | – | |
| – | +76.0% | -48.5% | +122.3% | -31.6% | -16.4% | +89.0% | +25.6% | -6.0% | +13.7% | +13.6% | +6.8% | +16.9% | +21.5% | -10.7% | +7.4% | +6.5% | -3.7% | -23.6% | +43.5% | -38.7% | +455.4% | -70.6% | +32.6% | -9.4% | -25.2% | – | |
| – | -21.6% | -5.4% | -15.6% | +33.7% | – | – | +31.3% | -5.9% | – | – | – | – | – | – | -7.8% | +2.7% | -25.7% | -8.9% | +53.8% | +16.0% | -53.6% | -12.4% | +12.8% | +7.2% | -17.1% | – | |
| – | -21.6% | +404.9% | +110.1% | -27.0% | -5.2% | +2,153.2% | -80.6% | -5.9% | +34.6% | -12.9% | +9.6% | +8.2% | -46.9% | -4.7% | -7.8% | +2.7% | -25.7% | +24.5% | +12.5% | +95.5% | +153.4% | -64.3% | +27.4% | -5.5% | -23.0% | – | |
| – | – | – | – | -148.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +63.1% | +16.6% | +0.4% | -2.6% | +1.3% | -30.8% | -63.7% | +1.8% | +0.0% | +0.0% | -1.7% | +1.8% | +0.0% | +0.0% | -1.7% | +1.8% | +0.0% | -34.5% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -168.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -172.1% | – | – | – | – | – | |
| – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -168.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -172.1% | – | – | – | – | – | |
| – | – | – | – | -163.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -172.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.